Venture Capital

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

A new partnership will deploy modular AI factories in Texas, aiming to solve the industry's critical power and speed bottlenecks with an innovative approach.

Wesley Pharmaceuticals launches a 503B-compliant NAD+ injection, promising quality in the booming anti-aging market amid scientific debate over its efficacy.

QuickLogic will showcase an eFPGA chiplet on Intel's 18A process at Chiplet Summit 2026, signaling a new era of flexible, post-silicon hardware design.

Katherine Stueland’s honor underscores a major shift in healthcare, as genomic screening and AI promise to end the diagnostic odyssey for rare diseases.

Krikey AI's new tool turns text into 3D social media videos, aiming to democratize animation and disrupt the creator economy. Is this the future of content?

Blink Charging and BetterFleet unite to offer a turnkey solution using AI and digital twins, aiming to de-risk and streamline EV fleet electrification.

A new collaboration with Datavant will securely connect real-world health data, aiming to speed up research and deliver life-saving therapies faster.

HeartCore Enterprises forecasts a dramatic swing to profitability in 2025 after divesting its software unit, betting its future on IPO consulting.

Financially robust and debt-free, Rail Vision is rapidly expanding its AI safety systems globally while a new quantum computing arm aims to redefine the future of rail.

BorgWarner secures a key contract for its advanced 800V drive module, signaling a major leap for range-extended EVs and its own market leadership.

New 3D human tissue models show groundbreaking promise in predicting toxicity for advanced cancer therapies, heralding a major shift away from animal testing.

A new study reveals employees are productive for just four hours a day. The surprising culprit isn't laziness—it's a lack of management structure.

A new Singapore venture aims to solve AI's biggest data jam, but its strategic exclusion of China signals a major geopolitical play in the tech arms race.

With key leadership promotions, AscellaHealth aims to streamline the complex path from drug discovery to patient delivery for life sciences companies worldwide.

As F1 enters a new era, Red Bull Ford Powertrains relies on Hexagon's sub-micron measurement tech to build its revolutionary 2026 engine from scratch.

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

With a 135% revenue surge and a key FDA submission for its kidney transplant drug, Hansa Biopharma is poised for a pivotal year of expansion.

With co-founder Tony Ngai now Co-President and CTO, Efinix is scaling its unique FPGA technology to capture the explosive demand in the edge AI market.

Jeff Hiller, Murray Hill, and Youngmi Mayer headline a NYC summit exploring the craft of sharing personal stories, reflecting a cultural shift toward authenticity.